Cannabis-based epilepsy treatment Epidiolex will cost $32,500 annually
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 29, 2018
CEO of GW Pharma talks about Epidiolex getting FDA approval
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 2, 2018
Rescheduling cannabis in the States: Could the decision backfire?
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• June 17, 2018
Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• May 3, 2018
FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• April 19, 2018
WHO declares CBD as safe for human consumption
February 22, 2018
New study: nearly 70 percent of CBD extracts labeled incorrectly
Sara Tiradossi
• November 10, 2017
A new bill could completely change cannabis research
September 20, 2017
Sessions further impedes cannabis research
Logan Lowrey-Rasmussen
• August 21, 2017
Load More Stories